Binding of β-TrCP and SMAD4 was noted to be enhanced in LINC00941-silenced cancer cells but conversely, LINC00941 overexpression significantly inhibited the binding of β-TrCP and SMAD4. The gene discussed is BTRC; the disease is cancer.